114 results
Page 5 of 6
6-K
EX-1.2
vgxspccx 2ci93jad23
30 May 14
Current report (foreign)
12:00am
F-3
3cjggjj2l3
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-1.1
6oscw
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B3
jgmfscv97
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
l6jk07
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
8lmk1lz7k wx106
15 Oct 12
Prospectus supplement
12:00am
F-1
43uam9
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
n8708xc5abiszt
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
9ufgr2xdf
27 Sep 12
Current report (foreign)
12:00am
S-8
EX-3.1
9xnrr4
19 Sep 12
Registration of securities for employees
12:00am
F-3/A
8cg209x9fg2m0hz
13 Aug 12
Shelf registration (foreign) (amended)
12:00am
F-3/A
EX-4.2
lbboweh
13 Aug 12
Shelf registration (foreign) (amended)
12:00am
424B3
755tj9
2 Aug 12
Prospectus supplement
12:00am
F-3
uxs3l1c5r
1 Aug 12
Shelf registration (foreign)
12:00am
POS AM
al8h zlmvbr
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
zfn85
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
424B3
pyt7zqah76zxbkgeshrw
28 Mar 12
Prospectus supplement
12:00am